ClinicalTrials.govpublic full text
Tandem High Dose Melphalan Versus Triple Intermediate Dose Melphalan and Stem Cell Transplantation in Induction Phase and Prednisolone/IFN Versus IFN in Maintenance Therapy
multiple myeloma, first line tretment, high dose chemotherapy, stem cell transplantation, maintenance therapy, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 889566
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.